Histidine triad nucleotide-binding protein 2 attenuates doxorubicin-induced cardiotoxicity through restoring lysosomal function and promoting autophagy in mice

Hao Jiang , Jinyan Zhang , Daile Jia , Liwei Liu , Jinfeng Gao , Beijian Zhang , Zhen Dong , Xiaolei Sun , Wenlong Yang , Tiantong Ou , Suling Ding , Luna He , Yiqin Shi , Kai Hu , Aijun Sun , Junbo Ge

MedComm ›› 2025, Vol. 6 ›› Issue (3) : e70075

PDF
MedComm ›› 2025, Vol. 6 ›› Issue (3) : e70075 DOI: 10.1002/mco2.70075
ORIGINAL ARTICLE

Histidine triad nucleotide-binding protein 2 attenuates doxorubicin-induced cardiotoxicity through restoring lysosomal function and promoting autophagy in mice

Author information +
History +
PDF

Abstract

Doxorubicin (DOX) is an effective chemotherapy drug widely used against various cancers but is limited by severe cardiotoxicity. Mitochondria–lysosome interactions are crucial for cellular homeostasis. This study investigates the role of histidine triad nucleotide-binding protein 2 (HINT2) in DOX-induced cardiotoxicity (DIC). We found that HINT2 expression was significantly upregulated in the hearts of DOX-treated mice. Cardiac-specific Hint2 knockout mice exhibited significantly worse cardiac dysfunction, impaired autophagic flux, and lysosomal dysfunction after DOX treatment. Mechanistically, HINT2 deficiency reduced oxidative phosphorylation complex I activity and disrupted the nicotinamide adenine dinucleotide NAD+/NADH ratio, impairing lysosomal function. Further, HINT2 deficiency suppressed sterol regulatory element binding protein 2 activity, downregulating transcription factor A mitochondrial, a critical regulator of complex I. Nicotinamide mononucleotide (NMN) supplementation restored lysosomal function in vitro, while cardiac-specific Hint2 overexpression using adeno-associated virus 9 or adenovirus alleviated DIC both in vivo and in vitro. These findings highlight HINT2 as a key cardioprotective factor that mitigates DIC by restoring the NAD+/NADH ratio, lysosomal function, and autophagy. Therapeutic strategies enhancing HINT2 expression or supplementing NMN may reduce cardiac damage and heart failure caused by DOX.

Keywords

autophagy / doxorubicin / HINT2 / lysosome / NAD +/NADH

Cite this article

Download citation ▾
Hao Jiang, Jinyan Zhang, Daile Jia, Liwei Liu, Jinfeng Gao, Beijian Zhang, Zhen Dong, Xiaolei Sun, Wenlong Yang, Tiantong Ou, Suling Ding, Luna He, Yiqin Shi, Kai Hu, Aijun Sun, Junbo Ge. Histidine triad nucleotide-binding protein 2 attenuates doxorubicin-induced cardiotoxicity through restoring lysosomal function and promoting autophagy in mice. MedComm, 2025, 6(3): e70075 DOI:10.1002/mco2.70075

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Barry E, Alvarez JA, Scully RE, Miller TL, Lipshultz SE. Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opin Pharmacother. 2007; 8(8): 1039-1058.

[2]

Vasquez-Vivar J, Martasek P, Hogg N, Masters BS, Pritchard KA, Jr, Kalyanaraman B. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry. 1997; 36(38): 11293-11297.

[3]

Berthiaume JM, Wallace KB. Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol. 2007; 23(1): 15-25.

[4]

de Baat EC, Mulder RL, Armenian S, et al. Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines. Cochrane Database Syst Rev. 2022; 9(9): CD014638.

[5]

Hasinoff BB, Schnabl KL, Marusak RA, Patel D, Huebner E. Dexrazoxane (ICRF-187) protects cardiac myocytes against doxorubicin by preventing damage to mitochondria. Cardiovasc Toxicol. 2003; 3(2): 89-99.

[6]

Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci USA. 2019; 116(7): 2672-2680.

[7]

Tadokoro T, Ikeda M, Ide T, et al. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight. 2020; 5(9).

[8]

Huang C, Zhang X, Ramil JM, et al. Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice. Circulation. 2010; 121(5): 675-683.

[9]

Wilkinson EL, Sidaway JE, Cross MJ. Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability. Biol Open. 2016;5(10): 1362-1370.

[10]

Rasanen M, Degerman J, Nissinen TA, et al. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection. Proc Natl Acad Sci USA. 2016; 113(46): 13144-13149.

[11]

Wallace KB, Sardao VA, Oliveira PJ. Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circ Res. 2020; 126(7): 926-941.

[12]

Govender J, Loos B, Marais E, Engelbrecht AM. Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin. J Pineal Res. 2014; 57(4): 367-380.

[13]

Li DL, Wang ZV, Ding G, et al. Doxorubicin blocks cardiomyocyte autophagic flux by inhibiting lysosome acidification. Circulation. 2016; 133(17): 1668-1687.

[14]

Martin J, Magnino F, Schmidt K, et al. Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. Gastroenterology. 2006; 130(7): 2179-2188.

[15]

Fan M, Chen Z, Huang Y, et al. Overexpression of the histidine triad nucleotide-binding protein 2 protects cardiac function in the adult mice after acute myocardial infarction. Acta Physiolog. 2020; 228(4): e13439.

[16]

Gu S, Tan J, Li Q, et al. Downregulation of LAPTM4B contributes to the impairment of the autophagic flux via unopposed activation of mTORC1 signaling during myocardial ischemia/reperfusion injury. Circ Res. 2020; 127(7): e148-e165.

[17]

Hossain MI, Marcus JM, Lee JH, et al. Restoration of CTSD (cathepsin D) and lysosomal function in stroke is neuroprotective. Autophagy. 2021; 17(6): 1330-1348.

[18]

Man SM, Kanneganti TD. Regulation of lysosomal dynamics and autophagy by CTSB/cathepsin B. Autophagy. 2016; 12(12): 2504-2505.

[19]

Baixauli F, Acín-Pérez R, Villarroya-Beltrí C, et al. Mitochondrial respiration controls lysosomal function during inflammatory T cell responses. Cell Metab. 2015; 22(3): 485-498.

[20]

Fernandez-Mosquera L, Yambire KF, Couto R, et al. Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis. Autophagy. 2019; 15(9): 1572-1591.

[21]

Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev. 2008; 88(2): 611-638.

[22]

Martin J, Maurhofer O, Bellance N, et al. Disruption of the histidine triad nucleotide-binding hint2 gene in mice affects glycemic control and mitochondrial function. Hepatology (Baltimore, Md). 2013; 57(5): 2037-2048.

[23]

Chen L, Sun Q, Zhou D, et al. HINT2 triggers mitochondrial Ca(2+) influx by regulating the mitochondrial Ca(2+) uniporter (MCU) complex and enhances gemcitabine apoptotic effect in pancreatic cancer. Cancer Lett. 2017; 411: 106-116.

[24]

Rajasekaran R, Felser A, Nuoffer JM, Dufour JF, St-Pierre MV. The histidine triad nucleotide-binding protein 2 (HINT-2) positively regulates hepatocellular energy metabolism. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2018; 32(9): 5143-5161.

[25]

Luo W, Zou X, Wang Y, et al. Critical role of the cGAS-STING pathway in doxorubicin-induced cardiotoxicity. Circ Res. 2023; 132(11): e223-e242.

[26]

Mizushima N, Levine B. Autophagy in human diseases. New Engl J Med. 2020; 383(16): 1564-1576.

[27]

Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011; 147(4): 728-741.

[28]

Kobayashi S, Volden P, Timm D, Mao K, Xu X, Liang Q. Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death. J Biol Chem. 2010; 285(1): 793-804.

[29]

Li M, Sala V, De Santis MC, et al. Phosphoinositide 3-kinase gamma inhibition protects from anthracycline cardiotoxicity and reduces tumor growth. Circulation. 2018; 138(7): 696-711.

[30]

Wang Y, Lu X, Wang X, et al. atg7-based autophagy activation reverses doxorubicin-induced cardiotoxicity. Circ Res. 2021.

[31]

Li S, Wang W, Niu T, et al. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Oxid Med Cell Long. 2014;2014:748524.

[32]

Wu X, Liu Z, Yu XY, Xu S, Luo J. Autophagy and cardiac diseases: therapeutic potential of natural products. Med Res Rev. 2021; 41(1): 314-341.

[33]

Bhatia D, Chung KP, Nakahira K, et al. Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis. JCI Insight. 2019; 4(23)

[34]

Ashrafi G, Schlehe JS, LaVoie MJ, Schwarz TL. Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J Cell Biol. 2014; 206(5): 655-670.

[35]

Borisov E, Bezsonov E, Lyukmanov D, Poggio P, Moschetta D, Valerio V. Pharmacological agents affecting mitophagy and inflammation. Vessel Plus. 2022; 6(0): 63.

[36]

Zhang Y, Wang Y, Xu J, et al. Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion/mitophagy and activating the AMPK-OPA1 signaling pathways. J Pineal Res. 2019; 66(2): e12542.

[37]

Schirone L, D’Ambrosio L, Forte M, et al. Mitochondria and doxorubicin-induced cardiomyopathy: a complex interplay. Cells. 2022; 11(13)

[38]

Deus CM, Yambire KF, Oliveira PJ, Raimundo N. Mitochondria-lysosome crosstalk: from physiology to neurodegeneration. Trends Mol Med. 2020; 26(1): 71-88.

[39]

Demers-Lamarche J, Guillebaud G, Tlili M, et al. Loss of mitochondrial function impairs lysosomes. J Biol Chem. 2016; 291(19): 10263-10276.

[40]

Wang KZ, Zhu J, Dagda RK, et al. ERK-mediated phosphorylation of TFAM downregulates mitochondrial transcription: implications for Parkinson’s disease. Mitochondrion. 2014; 17: 132-140.

[41]

Fiedorczuk K, Letts JA, Degliesposti G, Kaszuba K, Skehel M, Sazanov LA. Atomic structure of the entire mammalian mitochondrial complex I. Nature. 2016; 538(7625): 406-410.

[42]

Sazanov LA. A giant molecular proton pump: structure and mechanism of respiratory complex I. Nat Rev Mol Cell Biol. 2015; 16(6): 375-388.

[43]

Yagi M, Toshima T, Amamoto R, et al. Mitochondrial translation deficiency impairs NAD(+) - mediated lysosomal acidification. EMBO J. 2021; 40(8): e105268.

[44]

Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD(+) metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021; 22(2): 119-141.

[45]

Lee CF, Chavez JD, Garcia-Menendez L, et al. Normalization of NAD+ redox balance as a therapy for heart failure. Circulation. 2016; 134(12): 883-894.

[46]

Tong D, Schiattarella GG, Jiang N, et al. NAD(+) repletion reverses heart failure with preserved ejection fraction. Circ Res. 2021; 128(11): 1629-1641.

[47]

Yamamoto T, Byun J, Zhai P, Ikeda Y, Oka S, Sadoshima J. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PloS One. 2014; 9(6): e98972.

[48]

Jia D, Chen S, Bai P, et al. Cardiac resident macrophage-derived legumain improves cardiac repair by promoting clearance and degradation of apoptotic cardiomyocytes after myocardial infarction. Circulation. 2022; 145(20): 1542-1556.

[49]

Li X, You J, Dai F, et al. TAK1 activation by NLRP3 deficiency confers cardioprotection against pressure overload-induced cardiomyocyte pyroptosis and hypertrophy. JACC Basic Transl Sci. 2023; 8(12): 1555-1573.

[50]

Jiang H, Jia D, Zhang B, et al. Exercise improves cardiac function and glucose metabolism in mice with experimental myocardial infarction through inhibiting HDAC4 and upregulating GLUT1 expression. Basic Res Cardiol. 2020; 115(3): 28.

[51]

Stiernet P, Guiot Y, Gilon P, Henquin J-C. Glucose acutely decreases pH of secretory granules in mouse pancreatic islets. Mechanisms and influence on insulin secretion. J Biol Chem. 2006; 281(31): 22142-22151.

[52]

Ma J, Chen T, Wu S, et al. iProX: an integrated proteome resource. Nucleic Acids Res. 2019; 47(D1): D1211-D1217.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.

AI Summary AI Mindmap
PDF

210

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/